Carter's Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Carter's heeft een totaal eigen vermogen van $829.3M en een totale schuld van $497.9M, wat de schuld-eigenvermogensverhouding op 60% brengt. De totale activa en totale passiva bedragen respectievelijk $2.4B en $1.5B. De EBIT Carter's is $307.5M waardoor de rentedekking 15.3 is. Het heeft contanten en kortetermijnbeleggingen van $175.5M.
Belangrijke informatie
60.0%
Verhouding schuld/eigen vermogen
US$497.93m
Schuld
| Rente dekkingsratio | 15.3x |
| Contant | US$175.54m |
| Aandelen | US$829.34m |
| Totaal verplichtingen | US$1.55b |
| Totaal activa | US$2.38b |
Recente financiële gezondheidsupdates
Is Carter's (NYSE:CRI) A Risky Investment?
Sep 21
These 4 Measures Indicate That Carter's (NYSE:CRI) Is Using Debt Extensively
Nov 03Is Carter's (NYSE:CRI) Using Too Much Debt?
Jun 23Is Carter's (NYSE:CRI) A Risky Investment?
Mar 12Carter's (NYSE:CRI) Takes On Some Risk With Its Use Of Debt
Nov 30Recent updates
Return Trends At Carter's (NYSE:CRI) Aren't Appealing
Oct 30Carter's Q3 Disappointed And The Stock Is At A Decade Low, But Only Fairly Valued
Oct 28Is Carter's (NYSE:CRI) A Risky Investment?
Sep 21Earnings Working Against Carter's, Inc.'s (NYSE:CRI) Share Price
Sep 03Is Now An Opportune Moment To Examine Carter's, Inc. (NYSE:CRI)?
Aug 20Carter's, Inc. Just Recorded A 61% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 31Carter's: In Fairly Valued Territory, But There Will Be Better Opportunities Later
Jul 31Carter's: An Investment That Is Appealing To More Than Just Parents
Jun 17Carter's, Inc.'s (NYSE:CRI) Business And Shares Still Trailing The Market
May 22Carter's Excellent Business Is A Buy At P/B Ratios Below 3
May 02Is It Time To Consider Buying Carter's, Inc. (NYSE:CRI)?
Apr 24Carter's: With A 4.4% Yield, Pullback To Key Support Is A Buying Opportunity
Apr 15Be Wary Of Carter's (NYSE:CRI) And Its Returns On Capital
Apr 05Carter's (NYSE:CRI) Will Pay A Larger Dividend Than Last Year At $0.80
Mar 01Carter's: Taking A More Cautious Approach
Feb 13Pinning Down Carter's, Inc.'s (NYSE:CRI) P/E Is Difficult Right Now
Feb 09Is There Now An Opportunity In Carter's, Inc. (NYSE:CRI)?
Jan 24Carter's (NYSE:CRI) Has Some Way To Go To Become A Multi-Bagger
Jan 04Carter's (NYSE:CRI) Has Affirmed Its Dividend Of $0.75
Nov 24Carter's: Growth Concerns Despite FCF Strength
Nov 16These 4 Measures Indicate That Carter's (NYSE:CRI) Is Using Debt Extensively
Nov 03What Does Carter's, Inc.'s (NYSE:CRI) Share Price Indicate?
Oct 19Carter's, Inc. (NYSE:CRI) Shares Could Be 34% Above Their Intrinsic Value Estimate
Oct 04Investors Could Be Concerned With Carter's' (NYSE:CRI) Returns On Capital
Sep 17Carter's (NYSE:CRI) Will Pay A Dividend Of $0.75
Aug 28Carter's: A Dominant Player With Limited Upside
Jul 20What Does Carter's, Inc.'s (NYSE:CRI) Share Price Indicate?
Jul 10Is Carter's (NYSE:CRI) Using Too Much Debt?
Jun 23Carter's' (NYSE:CRI) Returns Have Hit A Wall
Jun 08Carter's' (NYSE:CRI) Dividend Will Be $0.75
May 23Are Carter's, Inc. (NYSE:CRI) Investors Paying Above The Intrinsic Value?
May 05Is It Too Late To Consider Buying Carter's, Inc. (NYSE:CRI)?
Apr 01Is Carter's (NYSE:CRI) A Risky Investment?
Mar 12Carter's (NYSE:CRI) Is Due To Pay A Dividend Of $0.75
Feb 27Carter's Q4 2022 Earnings Preview
Feb 23Carter's (NYSE:CRI) Has Some Way To Go To Become A Multi-Bagger
Feb 22Carter's Still Offers Upside, But A Watchful Eye Is Advised
Jan 24Carter's, Inc. (NYSE:CRI) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 23Is It Too Late To Consider Buying Carter's, Inc. (NYSE:CRI)?
Dec 27Carter's (NYSE:CRI) Takes On Some Risk With Its Use Of Debt
Nov 30Here's What To Make Of Carter's' (NYSE:CRI) Decelerating Rates Of Return
Nov 14Carter's: Continued Pressure On Revenue Growth And Margins
Nov 03Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.1B ) CRI } overtreffen de korte termijn passiva ( $484.1M ).
Langlopende schulden: De kortetermijnactiva CRI ( $1.1B ) overtreffen de langetermijnschulden ( $1.1B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 38.9% ) CRI wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van CRI is de afgelopen 5 jaar gedaald van 94.7% naar 60%.
Schuldendekking: De schuld van CRI wordt goed gedekt door de operationele kasstroom ( 67.2% ).
Rentedekking: De rentebetalingen op de schuld van CRI worden goed gedekt door EBIT ( 15.3 x dekking).